Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Streptococcus Uberis Bacterin
- Development stage
- Unknown
- Lead developer
- Hygieia Biological Laboratories
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Streptococcus Uberis Bacterin is an inactivated bacterial vaccine (bacterin) developed and manufactured by Hygieia Biological Laboratories. It is specifically designed to aid in the reduction of bovine mastitis caused by *Streptococcus uberis* in healthy adult dairy cattle and heifers. As the first USDA-licensed vaccine for this indication, it contains killed cultures of the pathogen to stimulate protective immunity. The vaccine is administered subcutaneously in a 5cc dose, typically following a three-dose initial protocol followed by boosters timed to the lactation cycle. Notably, it contains no antibiotics, which eliminates the need for a milk withdrawal period.
- Brand names
- Streptococcus Uberis Bacterin
- Other names
- Streptococcus uberis vaccineS. uberis bacterin
02
Targets
Streptococcus uberis surface and cell-wall antigens
Beyond the preview
Go deeper on Streptococcus Uberis Bacterin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Streptococcus Uberis Bacterin.